INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $640,242 | -20.5% | 20,248 | +2.5% | 0.00% | +100.0% |
| Q2 2023 | $805,201 | -19.6% | 19,745 | +43.3% | 0.00% | -90.0% |
| Q1 2022 | $1,002,000 | -44.9% | 13,783 | -10.3% | 0.01% | -44.4% |
| Q4 2021 | $1,818,000 | -70.0% | 15,370 | -66.0% | 0.02% | -78.0% |
| Q3 2021 | $6,069,000 | -24.1% | 45,243 | -8.4% | 0.08% | -27.4% |
| Q2 2021 | $7,999,000 | +76.6% | 49,404 | -12.5% | 0.11% | +56.9% |
| Q1 2021 | $4,530,000 | +158.6% | 56,436 | +75.2% | 0.07% | +157.1% |
| Q4 2020 | $1,752,000 | +192.5% | 32,212 | +6.9% | 0.03% | +154.5% |
| Q3 2020 | $599,000 | +81.5% | 30,131 | +91.9% | 0.01% | +57.1% |
| Q2 2020 | $330,000 | – | 15,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |